Kenneth A Katz. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AlefaceptClinical Trials as TopicHumansImmunosuppressive Agents/therapeutic useMethotrexate/therapeutic useOutcome Assessment, Health CarePsoriasis/drug therapyQuality of LifeRecombinant Fusion Proteins/therapeutic useRetreatmentSeverity of Illness Index
Substances： See more » Immunosuppressive AgentsRecombinant Fusion ProteinsAlefaceptMethotrexate
Year: 2005 PMID： 16112384 DOI： 10.1016/j.jaad.2005.06.017
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527